GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Mega Lifesciences PCL MEGA.BK · THB

Health Care · SET · 🇹🇭 Thailand

Compare

35.50

+0.71%

Close of 9 Nov 2026, in THB

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in THB, from our data supplier.

FY2025

Revenue

THB 14.15bn

FY2016FY2025

Net income

THB 1.91bn

FY2016FY2025

Free cash flow

THB 2.14bn

FY2016FY2025

Shareholders' equity

THB 10.22bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTHB 14.15bnTHB 15.34bnTHB 15.68bnTHB 15.69bnTHB 14.14bnTHB 12.59bnTHB 11.13bnTHB 10.34bnTHB 9.60bnTHB 8.81bn
Gross profitTHB 7.27bnTHB 7.75bnTHB 6.98bnTHB 7.04bnTHB 5.91bnTHB 4.99bnTHB 4.58bnTHB 4.59bnTHB 4.32bnTHB 3.69bn
Research and developmentTHB 56.3mTHB 44.0mTHB 41.3mTHB 44.4mTHB 40.5mTHB 27.4mTHB 27.2mTHB 29.2mTHB 29.9mTHB 32.7m
Operating incomeTHB 2.90bnTHB 3.37bnTHB 2.90bnTHB 2.72bnTHB 2.17bnTHB 1.67bnTHB 1.43bnTHB 1.45bnTHB 1.38bnTHB 955.1m
Net incomeTHB 1.91bnTHB 2.01bnTHB 1.99bnTHB 2.24bnTHB 1.95bnTHB 1.39bnTHB 1.14bnTHB 1.21bnTHB 1.11bnTHB 794.9m
Diluted earnings per share2.192.312.292.572.221.591.311.391.280.92

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTHB 16.00bnTHB 14.21bnTHB 14.52bnTHB 14.65bnTHB 13.27bnTHB 11.59bnTHB 10.53bnTHB 9.63bnTHB 8.72bnTHB 7.94bn
Cash and short-term investmentsTHB 4.64bnTHB 3.81bnTHB 2.71bnTHB 2.79bnTHB 2.53bnTHB 1.22bnTHB 1.46bnTHB 926.9mTHB 1.17bnTHB 1.22bn
Total liabilitiesTHB 5.78bnTHB 4.33bnTHB 5.22bnTHB 5.87bnTHB 5.25bnTHB 4.61bnTHB 4.36bnTHB 3.91bnTHB 3.48bnTHB 3.26bn
DebtTHB 537.3mTHB 491.2mTHB 251.8mTHB 420.9mTHB 356.3mTHB 647.5mTHB 890.5mTHB 959.8mTHB 512.2mTHB 669.7m
Shareholders' equityTHB 10.22bnTHB 9.88bnTHB 9.30bnTHB 8.78bnTHB 8.00bnTHB 6.96bnTHB 6.17bnTHB 5.72bnTHB 5.24bnTHB 4.68bn
Shares outstanding872m872m872m872m877m878m872m869m870m867m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTHB 2.81bnTHB 2.40bnTHB 1.93bnTHB 2.00bnTHB 2.73bnTHB 1.63bnTHB 1.50bnTHB 919.4mTHB 927.0mTHB 1.26bn
Capital spending−THB 663.9m−THB 257.3m−THB 274.6m−THB 312.7m−THB 159.8m−THB 255.1m−THB 540.8m−THB 751.9m−THB 227.9m−THB 298.4m
Free cash flowTHB 2.14bnTHB 2.14bnTHB 1.65bnTHB 1.68bnTHB 2.57bnTHB 1.37bnTHB 954.3mTHB 167.5mTHB 699.2mTHB 962.1m
Dividends paid−THB 1.39bn−THB 1.39bn−THB 1.44bn−THB 1.41bn−THB 922.9m−THB 670.2m−THB 618.1m−THB 614.5m−THB 467.3m−THB 407.4m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTHB 3.53bnTHB 3.41bnTHB 3.66bnTHB 3.88bnTHB 3.40bnTHB 3.21bnTHB 3.66bnTHB 4.00bn
Gross profitTHB 1.83bnTHB 1.78bnTHB 1.95bnTHB 2.03bnTHB 1.73bnTHB 1.67bnTHB 1.96bnTHB 2.13bn
Operating incomeTHB 590.8mTHB 749.0mTHB 780.2mTHB 924.0mTHB 588.7mTHB 609.8mTHB 876.4mTHB 465.9m
Net incomeTHB 514.6mTHB 604.5mTHB 577.0mTHB 494.2mTHB 390.9mTHB 449.8mTHB 639.4mTHB 382.6m
Diluted earnings per share0.590.690.660.570.450.520.730.44
Cash from operationsTHB 173.0mTHB 689.0mTHB 1.07bnTHB 854.0mTHB 461.0mTHB 397.0mTHB 800.0m−THB 4.0m
Capital spending−THB 158.0m−THB 95.0m−THB 233.0m−THB 60.0m−THB 100.0m−THB 270.0m−THB 61.0m−THB 94.0m
Free cash flowTHB 15.0mTHB 594.0mTHB 842.0mTHB 794.0mTHB 361.0mTHB 127.0mTHB 739.0m−THB 98.0m
Total assetsTHB 16.15bnTHB 16.29bnTHB 16.00bnTHB 14.65bnTHB 14.31bnTHB 14.36bnTHB 14.21bnTHB 13.53bn
Cash and short-term investmentsTHB 4.02bnTHB 4.65bnTHB 4.64bnTHB 3.77bnTHB 3.71bnTHB 3.91bnTHB 3.81bnTHB 2.92bn
DebtTHB 579.6mTHB 543.2mTHB 602.4mTHB 495.1mTHB 504.8mTHB 330.8mTHB 351.4mTHB 233.4m
Shareholders' equityTHB 10.34bnTHB 10.51bnTHB 10.22bnTHB 9.68bnTHB 9.95bnTHB 10.32bnTHB 9.88bnTHB 9.24bn

Financial ratios

Data as of 21 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin51.4%50.5%44.5%44.9%41.8%39.6%
Operating margin20.5%22.0%18.5%17.4%15.3%13.2%
Net margin13.5%13.1%12.7%14.3%13.8%11.1%
Return on equity18.7%20.4%21.4%25.5%24.3%20.0%
Return on assets12.0%14.2%13.7%15.3%14.7%12.0%
Free cash flow yield11.1%8.5%7.1%7.4%9.2%6.0%
Revenue growth-7.8%-2.1%-0.0%11.0%12.3%13.1%
Earnings growth-5.0%1.0%-11.1%15.1%39.8%22.3%
Current ratio2.23x2.61x2.25x1.91x1.92x1.79x
Debt to equity0.05x0.04x0.01x0.04x0.03x0.08x
Equity ratio63.9%69.5%64.1%59.9%60.3%60.0%
Interest coverage52.70x87.54x92.93x94.72x76.74x23.04x
R&D as a share of sales0.4%0.3%0.3%0.3%0.3%0.2%
Buybacks as a share of market value0.0%0.0%0.0%0.6%0.1%-0.7%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-3.4%2.4%5.9%
Operating income2.2%11.8%15.1%
Net income-5.2%6.5%10.6%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin50.9%47.7%45.6%44.7%
Operating margin21.3%19.6%18.0%16.0%
Net margin13.3%13.4%13.1%12.1%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings15.314.417.618.222.822.519.920.734.427.5
Price to sales2.11.92.22.63.12.52.02.44.02.5

Dividends and splits

Per share, in the currency the company pays

Paid for 12 years. Last went ex-dividend on 26 Aug 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year1.651.601.601.650.450.340.560.40

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.